About RMOS

The Regenerative Medicine Orthopaedic Society (RMOS) was brought to life in 2022 by Prof. Tahsin Beyzadeoglu and Ass. Prof. George Skarpas. Fueled by a shared conviction in the potential of regenerative medicine to revolutionize orthopaedics, they saw the need for a dedicated forum to promote, explore, and advance this innovative field.

Their vision became the blueprint for RMOS – an organization dedicated to transforming orthopaedic care through regenerative medicine. In this pursuit, we are guided by an unwavering commitment to scientific integrity, patient welfare, and the creation of an inclusive, collaborative community.

Our society is a vibrant and diverse network of orthopaedic surgeons, researchers, healthcare professionals, biotech firms, and policy advocates. This broad coalition brings together complementary skills, experiences, and perspectives, fostering an environment that encourages learning, knowledge exchange, and collaboration. Each member contributes uniquely to the evolution of our field and benefits from the shared knowledge and opportunities provided by the society.

Since our inception, RMOS has been at the forefront of breakthroughs in regenerative medicine applied to orthopaedics. We have conducted successful international summits, bringing together experts from around the world to share insights and drive progress. These gatherings have served as vital platforms for knowledge dissemination, idea generation, and collaborations that propel the advancement of regenerative medicine within orthopaedics.

Our success has also been fueled by significant collaborations with other organizations, academic institutions, and industry partners. These strategic alliances have not only expanded our reach but also enriched our resources and capabilities. Together, we strive to navigate the challenges and opportunities in our path to ensure that regenerative medicine reaches its full potential in orthopaedics.

Looking towards the future, RMOS is committed to building upon its robust foundation. We aim to expand our global footprint, increase membership, boost our research contributions, and enhance our educational programs. Above all, we continue to prioritize our central goal – to improve patient outcomes and quality of life by incorporating regenerative medicine in the standard orthopaedic practice.

At RMOS, we believe that our collective efforts will forge a new era in orthopaedics where regenerative therapies become mainstream, marking a significant leap forward in patient care.